Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma, metastatic
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Bronchioloalveolar Adenocarcinoma
|
5 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Malignant neoplasm of ovary
|
315 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
ovarian neoplasm
|
757 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Mucoepidermoid Carcinoma
|
6 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Advanced lung cancer
|
9 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Mucinous Adenocarcinoma
|
10 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Secondary malignant neoplasm of lymph node
|
188 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Squamous cell carcinoma of the head and neck
|
348 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Tumor Progression
|
72 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Small cell carcinoma of lung
|
125 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.030 | 1.000 | 3 | 2007 | 2013 | ||||||
Adenocarcinoma of small intestine
|
5 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Adult Penile Carcinoma
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Malignant neoplasm of penis
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Penis carcinoma
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Laryngeal Squamous Cell Carcinoma
|
30 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Li-Fraumeni Syndrome
|
206 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Seborrheic keratosis
|
21 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Pleural Effusion, Malignant
|
6 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
Breast Carcinoma
|
2793 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||
Carcinoma
|
103 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Carcinoma breast stage IV
|
14 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Lymphatic Metastasis
|
10 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Triple Negative Breast Neoplasms
|
99 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 |